4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Clinical Trials in Cardiology
The design and execution of clinical trials in cardiology adhere to rigorous scientific and ethical standards. Large-scale trials often involve collaboration between multiple research centers and may span several years to gather robust and statistically significant data. Patient recruitment, informed consent, and adherence to strict protocols are fundamental aspects of conducting ethical clinical trials. The outcomes of these trials guide healthcare professionals in making evidence-based decisions about the adoption of new therapies, shaping clinical guidelines and influencing standards of care. As technology and understanding of cardiovascular diseases advance, clinical trials play a pivotal role in translating scientific discoveries into tangible benefits for patients, fostering innovation, and continuously improving the landscape of cardiology practice.
Shuping Zhong
University of Southern California, United States
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Miroslav Radenkovic
University of Belgrade, Serbia
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : A diabetic sweetheart facing a sour ending!
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Perception of cardiovascular risk in women after a rehabilitation program
Maria Teresa Carvallo Marin, Privado , Chile